Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway

Non-alcoholic fatty liver disease (NAFLD) is a potentially serious disease that affects 30 % of the global population and poses a significant risk to human health. However, to date, no safe, effective and appropriate treatment modalities are available. In recent years, ferroptosis has emerged as a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Tianyu, Xiao, Yao, Zhou, Jinfeng, Luo, Zupeng, Yu, Lin, Liao, Qichao, Liu, Siqi, Qi, Xinyi, Zhang, Hao, Hou, Menglong, Miao, WeiWei, Batsaikhan, Batbold, Damba, Turtushikh, Liang, Yunxiao, Li, Yixing, Zhou, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694775/
https://www.ncbi.nlm.nih.gov/pubmed/37984229
http://dx.doi.org/10.1016/j.redox.2023.102963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694775/
https://www.ncbi.nlm.nih.gov/pubmed/37984229
http://dx.doi.org/10.1016/j.redox.2023.102963

Ejemplares similares